DystoniaChurg-Strauss SyndromeParkinson DiseaseVasculitisDystonic DisordersDystonia Musculorum Deformansalpha-SynucleinTorticollisAntiparkinson AgentsParkinsonian DisordersLevodopaDeep Brain StimulationParkinson Disease, SecondaryGlucosylceramidaseLewy BodiesSubstantia NigraGlobus PallidusAnti-Dyskinesia AgentsDopamineSubthalamic Nucleus1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineMultiple System AtrophyDopaminergic NeuronsEssential TremorMovement DisordersLewy Body DiseasePutamenGait Disorders, NeurologicBlepharospasmMeige SyndromePostural BalanceOxidopamineNeurodegenerative DiseasesMPTP PoisoningSupranuclear Palsy, ProgressiveDance TherapyAge of OnsetBrainMuscle CrampNeuronsUbiquitin-Protein LigasesHypokinesiaCorpus StriatumBasal GangliaGaitPedunculopontine Tegmental NucleusDyskinesia, Drug-InducedTyrosine 3-MonooxygenaseMutationDyskinesiasNerve DegenerationGaucher DiseaseREM Sleep Behavior DisorderPergolidebeta-SynucleinOncogene ProteinsGenetic Predisposition to DiseaseSeverity of Illness IndexDementiaCarbidopaManebSensation DisordersDopamine AgentsStereotaxic TechniquesDisease Models, AnimalElectromyographyNeuropsychological TestsBotulinum ToxinsMolecular ChaperonesCase-Control StudiesTremorMitochondriaHandwritingMesencephalonNeuromuscular AgentsDopamine Plasma Membrane Transport ProteinsHandManganese PoisoningSynucleinsPositron-Emission TomographyBotulinum Toxins, Type ANeurologic Examination1-Methyl-4-phenylpyridiniumNeuroprotective AgentsNocturnal Paroxysmal DystoniaTropanesMovementMotor SkillsGenetic TestingSleep Arousal DisordersEntopeduncular NucleusDeglutition DisordersApathyBenzothiazolesPrimary DysautonomiasGTP CyclohydrolaseBasal Ganglia DiseasesDNA Mutational AnalysisPedigreePostmortem Changes